As of today (2024-04-25), the Trailing Annual Dividend Yield of Trinity Biotech is 0.00%.
The historical rank and industry rank for Trinity Biotech's Dividend Yield % or its related term are showing as below:
During the past 13 years, the highest Dividend Yield of Trinity Biotech was 2.33%. The lowest was 0.72%. And the median was 1.19%.
TRIB's Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.025 * Ranked among companies with meaningful Dividend Yield % only.
Trinity Biotech's Dividend Payout Ratio for the
three
months ended in Sep. 2023 was 0.00.
During the past 13 years, the highest Dividend Payout Ratio of Trinity Biotech was 0.50. The lowest was 0.34. And the median was 0.46.
Trinity Biotech's Dividends per Share for the
three
months ended in Sep. 2023 was $0.00.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Trinity Biotech was 30.10% per year. The lowest was 13.60% per year. And the median was 21.85% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Trinity Biotech Dividend Yield % Historical Data
The historical data trend for Trinity Biotech's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Trinity Biotech's Dividend Yield %
For the Diagnostics & Research subindustry, Trinity Biotech's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trinity Biotech's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Trinity Biotech's Dividend Yield % falls into.
Trinity Biotech Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thank you for viewing the detailed overview of Trinity Biotech's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Trinity Biotech (Trinity Biotech) Business Description
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TRIB has been successfully added to your 